AJANTA PHARMA Share price, NSE/BSE Forecast News and Quotes| Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Share Price   (AJPH)

Here is the latest stock price and chart of AJANTA PHARMA. For more details, see the AJANTA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Oct 17, 2018 10:43:00 AM
Price (Rs)1,014.60 Open (Rs) 1,035.40 High (Rs) 1,037.90 Low (Rs) 1,010.00
% Change-1.28 Volume 4,711 Value (Rs) 4,779,781 52-Week H/L 1,592.00 / 897.60
Live NSE Quotes Oct 17, 2018 10:44:59 AM
Price (Rs)1,015.50 Open (Rs) 1,032.05 High (Rs) 1,039.90 Low (Rs) 1,007.95
% Change-1.13 Volume 70,293 Value (Rs) 71,883,028 52-Week H/L 1,595.00 / 895.85
Valuation
EPS (Rs)* 54.54 P/E Ratio (x) 18.60 Market Cap (Rs m) 89,234.07 P/BV (x) 4.37
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AJANTA PHARMA Share Price Today:

AJANTA PHARMA share price is down 1.3% to Rs 1,014.6 on the BSE. On the NSE, the AJANTA PHARMA share price is down 1.1% to Rs 1,015.5. The total volume of shares traded is 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading down by 0.5%. And the benchmark S&P BSE SENSEX is at 35,308.0 (up 0.4%).

Over the last 30 days, the AJANTA PHARMA share price is down 15.9%. And over the last one year, AJANTA PHARMA share price is down 15.5%.





Today's Market

Sensex Opens Over 300 Points Up; Infosys Rallies on Strong Q2 Result(09:30 am)

Asian stocks are higher today. Japan's Nikkei rose 1.3%. MSCI's broadest index of Asia-Pacific shares outside Japan added 0.5% and South Korea 1.5%.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 11.6% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 11.6% YoY). Sales on the other hand came in at Rs 5 bn (up 8.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 17.1% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, AJANTA PHARMA has posted a net profit of Rs 945 m (down 17.1% YoY). Sales on the other hand came in at Rs 5 bn (up 11.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS